BridgeMD
New treatment option for Sickle Cell Disease
Official title MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
ClinicalTrials.gov ID: NCT06853158
What this study is testing
- What it's testing
- This is a multi-site, multi-visit feasibility RCT of music therapy (MT) among adolescent and adult patients (aged 14 and older) with sickle cell disease (SCD). Subjects will be randomized into one of three groups, either (1) 6 visits of in- person MT (InMT:); (2) 1 visit of in-person MT and 5 visits of virtual MT (HybMT); or (3) 1 visit of in-person health education and 5 visits of virtual health education (HybHE).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 and older
You may be able to join if
- Be aged \>=14 years old
- Have a diagnosis of SCD present in their electronic health record (EHR);
- Meet Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks-American Pain Society Pain Taxonomy...
- Palpation of the region of reported pain elicits focal pain or tenderness;
- Movement of the region of reported pain elicits focal pain;
You likely can't join if
- Have a significant visual, hearing, or cognitive impairment
- Have previously participated in the MUSIQOLS single-site pilot study at University Hospitals in 2018
- Are currently engaging in mind-body therapies under the supervision of a healthcare professional specifically for pain management
- Have a planned major medical event in the next 14 weeks such as (but not limited to) childbirth, orthopedic surgery, gene therapy, or stem cell...
See the full eligibility criteria
- Be aged \>=14 years old
- Have a diagnosis of SCD present in their electronic health record (EHR);
- Meet Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks-American Pain Society Pain Taxonomy (AAPT) criteria for chronic SCD pain which includes: 3a. A diagnosis of...
- Palpation of the region of reported pain elicits focal pain or tenderness;
- Movement of the region of reported pain elicits focal pain;
- Decreased range of motion or weakness in the region of reported pain;
- Evidence of skin ulcer in the region of reported pain;
- Evidence of hepatobiliary or splenic imaging abnormalities (e.g., splenic infarct, chronic pancreatitis) consistent with the region of reported pain; or
- Evidence of imaging abnormalities consistent with bone infarction or avascular necrosis in the region of reported; 3d. There is no other diagnosis that better explains the signs and symptoms (to be obtained from...
- Have a significant visual, hearing, or cognitive impairment
- Have previously participated in the MUSIQOLS single-site pilot study at University Hospitals in 2018
- Are currently engaging in mind-body therapies under the supervision of a healthcare professional specifically for pain management
- Have a planned major medical event in the next 14 weeks such as (but not limited to) childbirth, orthopedic surgery, gene therapy, or stem cell transplant (These criteria do not include blood transfusions, exchange...
The study team makes the final eligibility decision.
Where it's taking place
- Cleveland, Ohio, United States
- Greenville, South Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cleveland, Ohio, United States; Greenville, South Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.